Ledger.Open graph →
SEC Form D · filed April 5, 2019

MINERVA BIOTECHNOLOGIES Corp

Offering
$12.0M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Michael Cassara · San Diego, CADirectorCynthia Bamdad · Waltham, MAExec · DirectorKenneth Kosik · Waltham, MADirectorMichael Skead · Vancouver, British Columbia, CanadaDirectorJames R. Bridges · Waltham, MADirectorRonald E. Osman · Saint Louis, MODirectorLawrence A. Coolidge · Waltham, MADirectorBrent Eley · Bellevue, WADirectorJoseph A. Nathan · Waltham, MADirectorKenneth A. Reed · Waltham, MADirectorMilton Pinsky · Northbrook, ILExec · DirectorTaylor Hobbs · Waco, TXDirectorBenjamin Alfonsi · New York, NYDirectorLowell J. Burnett · San Diego, CADirectorBrad Sargent · Cupertino, CADirectorAndrew Rosen · New York, NYDirectorJames V. O'Donnell · Saint Louis, MODirectorRobert Staszewski · Waltham, MADirectorNormand F. Smith · Waltham, MADirectorBrandon Jundt · Denver, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗